SEC Form 4 · accession 0001513162-15-000397
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Andrew Berman
Officer — President and CEO · Director
Period of report
Jul 10, 2015
Accepted (ET)
Jul 14, 2015 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 10, 2015 | P | 200 | $4.00 | A | 40,558 | D |
Table II — derivative securities
No Table II lines on this filing.